Paul Kelly - Profile and Investment Details

Investor Profile

Paul Kelly is a Venture Capital, Private Equity Firm based in Sydney, New South Wales, Australia with a diverse investment portfolio that includes companies such as AdGent Digital, OVO, Prota Therapeutics, Clinical Genomics Technologies, Smart Sparrow, Zoomo, Employment Hero, Hatchtech, Find-Me Technologies Pty Ltd, Peak3, Shippit, Kira Biotech, Paragen Bio, 8i, Incoming Media, Murdoch Childrens Research Institute (MCRI)Hometime, BiVACOR, Vaxxas, Blade Therapeutics, Paloma Mobile, Beasy, Phocas, Madorra, . Over time, Paul Kelly has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Paul Kelly is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Autonomous Vehicles, E-commerce, Women Founded, Enterprise Software, HR Tech, Fleet Management, Android, Life Science, Sharing Economy, Banking, Robotics, Information Technology (IT), Finance, Software, Manufacturing, Biotechnology, Food and Beverage, Employee Benefits, Consumer Internet, Logistics, Subscription Businesses, Travel, Medical, SaaS, Real Estate, Therapeutics, Pharmaceuticals may find it worthwhile to explore potential connections with Paul Kelly, as their portfolio suggests a familiarity and interest in this area.

Understanding Paul Kelly’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.